Franklin Resources
KERX

Franklin Resources’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Franklin Resources’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-836,515
Closed -$4.22M – 1582
2015
Q4 		$4.22M Sell
836,515
-4,226,228
-83% -$20.1M ﹤0.01% 1165
2015
Q3 		$17.8M Sell
5,062,743
-1,512,209
-23% -$10.1M 0.01% 876
2015
Q2 		$65.6M Sell
6,574,952
-153,642
-2% -$1.65M 0.03% 515
2015
Q1 		$85.7M Buy
6,728,594
+1,384,094
+26% +$17.8M 0.04% 439
2014
Q4 		$75.6M Buy
5,344,500
+435,211
+9% +$6.74M 0.03% 462
2014
Q3 		$67.5M Buy
4,909,289
+1,962,389
+67% +$30M 0.03% 487
2014
Q2 		$45.3M Sell
2,946,900
-95,500
-3% -$1.35M 0.02% 633
2014
Q1 		$51.8M Buy
3,042,400
+657,100
+28% +$9.91M 0.02% 564
2013
Q4 		$30.9M Sell
2,385,300
-384,600
-14% -$4.59M 0.02% 692
2013
Q3 		$28M Buy
2,769,900
+522,600
+23% +$4.65M 0.01% 715
2013
Q2 		$16.8M Buy
+2,247,300
New +$17.6M 0.01% 803

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources's KERX Position: Q1 2016 in Review

Franklin Resources sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2016, closing a stake of 836,515 shares — an estimated $4.22M sold.

Franklin Resources first reported a position in KERX in Q2 2013 and held it in 11 quarters. The position peaked at $85.7M in Q1 2015. 130 funds tracked by Wall St. Rank hold KERX as of Q1 2016.

  • Franklin Resources reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Franklin Resources sold 836,515 Keryx Biopharmaceuticals Inc shares in Q1 2016, an estimated $4.22M.
  • Franklin Resources first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • Franklin Resources's Keryx Biopharmaceuticals Inc position peaked at $85.7M in Q1 2015.
  • 130 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2016.

Based on Franklin Resources's 13F filing for Q1 2016, filed 10 May 2016.